Tiger Brokers

Sensient Technologies Reports 2.7% Increase in Q2 Revenue, 20.5% Rise in EPS

Reuters
Jul 25, 2025
Sensient Technologies Reports 2.7% Increase in <a href="https://laohu8.com/S/QTWO">Q2</a> Revenue, 20.5% Rise in EPS

Sensient Technologies Corporation, a leader in flavors and colors for the food, pharmaceutical, and personal care markets, has reported its financial results for the second quarter ended June 30, 2025. The company experienced a reported revenue increase of 2.7%, reaching $414.2 million, compared to $403.5 million in the same quarter of the previous year. On a local currency basis, revenue increased by 2.1%. The company's reported operating income rose by 16.2% to $57.7 million from $49.7 million in the second quarter of 2024. Additionally, Sensient recorded $3.3 million in costs related to its Portfolio Optimization Plan during this period, compared to $1.8 million in the previous year. Local currency adjusted operating income and local currency adjusted EBITDA saw increases of 16.9% and 14.1%, respectively. Reported earnings per share $(EPS)$ increased by 20.5%, reaching 88 cents in the second quarter of 2025, up from 73 cents in the same period of 2024. The local currency adjusted diluted EPS rose by 20.8%. Sensient's Chairman, President, and CEO, Paul Manning, expressed confidence in the company's ongoing performance, highlighting a strong first quarter and a continued focus on customer service and innovation. Manning remains optimistic about Sensient's performance in 2025 and beyond.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sensient Technologies Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250724311379) on July 25, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10